Prolonged exposure of colon cancer cells to 5-fluorouracil nanoparticles improves its anticancer activity
Open Access
- 1 February 2017
- journal article
- research article
- Published by Springer Nature in Saudi Pharmaceutical Journal
- Vol. 25 (2) , 206-213
Abstract
In this study, we aimed to improve the anticancer effect of 5-FU on human colon cancer cell lines by incorporating in poly(d,l lactic-co-glycolic acid) (PLGA) nanoparticles (NPs). The 5-FU-PLGA NPs were prepared by nanoprecipitation technique. Prepared NPs were moderately dispersed with an average diameter of 133 ± 25.19 nm. Scanning Electron Microscope (SEM) images revealed spherical structures with subtle surface irregularity. Free 5-FU dose-response curves were constructed (12.5-2000 μM) using MTT assay on HCT 116 and HT-29 cell lines for 1, 3, and 5 days. The calculated IC50 on HCT 116 were 185 μM after 1 day, 11.3 μM after 3 days, and 1.48 μM after 5 days. On HT-29, IC50 was only reached after 5 days of 5-FU treatment (11.25 μM). The HCT 116 viability following treatment with 100 μM 5-FU in free or NPs forms for 3 days was 38.8% and 18.6%, respectively. Similarly, when 250 μM was applied, HCT 116 viability was 17.03% and 14.6% after treatment with free and NPs forms of 5-FU, respectively. Moreover, HT-29 cell viability after 250 μM 5-FU treatment in free or NPs forms was 55.45% and 34.01%, respectively. We also noticed that HCT 116 cells were more sensitive to 5-FU-PLGA NPs as compared to HT-29 cells. Overall, our data indicate that 5-FU activity is time dependent and the prolonged effects created by PLGA NPs may contribute, at least in part, to the noticed enhancement of the anticancer activity of 5-FU drug.Keywords
Funding Information
- Research Groups Program
This publication has 34 references indexed in Scilit:
- Preparation and characterization of electrospun PLGA/gelatin nanofibers as a drug delivery system by emulsion electrospinningJournal of Biomaterials Science, Polymer Edition, 2012
- Biological evaluation of 5-fluorouracil nanoparticles for cancer chemotherapy and its dependence on the carrier, PLGAInternational Journal of Nanomedicine, 2011
- Synthetic polymeric nanoparticles by nanoprecipitationJournal of Materials Chemistry, 2009
- Magnetic Colloids As Drug VehiclesJournal of Pharmaceutical Sciences, 2008
- PLGA Nanoparticles for the Oral Delivery of 5-Fluorouracil Using High Pressure Homogenization-Emulsification as the Preparation Method and In Vitro/In Vivo StudiesDrug Development and Industrial Pharmacy, 2008
- 5-Fluorouracil Activation of p53 Involves an MDM2-Ribosomal Protein InteractionJournal of Biological Chemistry, 2007
- Enhanced liver targeting of 5-fluorouracil using galactosylated human serum albumin as a carrier moleculeJournal of Drug Targeting, 2006
- Poly(D,L-Lactide-Co-Glycolide) microspheres containing 5-fluorouracil: Optimization of process parametersAAPS PharmSciTech, 2003
- Encapsulation of Hydrophilic and Lipophilic Drugs in PLGA Nanoparticles by the Nanoprecipitation MethodDrug Development and Industrial Pharmacy, 1999
- Biodegradable poly(lactic acid) and poly(lactide-co-glycolide) microcapsules: problems associated with preparative techniques and release propertiesJournal of Microencapsulation, 1990